Apr 29, 2020
FDA approves Zejula (niraparib) as the only once-daily PARP inhibitor in first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer regardless of biomarker status
Apr 29, 2020
Jazz Pharmaceuticals Stops Enrollment in Phase 3 Study Evaluating Defibrotide for the Prevention of Veno-Occlusive Disease
Apr 15, 2020
The central intravenous catheters market is expected to grow at a CAGR of over 5% during the period 2019-2025
Apr 14, 2020
Antengene Announces Dosing of First Patient in the ATG-019 (KPT-9274) Phase 1 Trial, a First-in-Class Dual Inhibitor, for Advanced Solid Tumors and Non-Hodgkin's Lymphoma
Apr 08, 2020
Trovagene to Present at the 19th Annual Needham Healthcare Conference
Mar 31, 2020
Global Antibody Drug Conjugates Drug Sales, Pipeline Analysis (By Phase, Linker, Technology, and Indication) & Global Market Forecasts to 2023
Mar 31, 2020
Caris Life Sciences Launches MI FOLFOXai, Improving Overall Survival by 50% for Metastatic Colorectal Cancer Patients
Mar 25, 2020
Juntendo University Research: A New Combination Therapy is Effective in Treating a Rare Blood Cancer Cell Type
Mar 24, 2020
OncoQuest Announces Publication of Two Reports Related to Oregovomab Phase 2 Clinical Trial, the Company's Lead Investigational Drug in Frontline Ovarian Cancer
Mar 24, 2020
Global Catheter-Related Bloodstream Infection (CRBSI) Industry Insights, Epidemiology, and Outlook to 2028
Mar 19, 2020
Melanoma Is Killing Fewest Americans in Decades
Mar 19, 2020
ISA Pharma Publishes Phase 2 Study Data in Major Peer-reviewed Journal
Mar 09, 2020
The global elastomer infusion pump market was valued at $534 million in 2018, and is estimated to reach at $745 million by 2026, registering a CAGR of 4.2% from 2019 to 2026
Mar 05, 2020
Outlook on the $320M+ Bladder Cancer Drugs Market, 2020-2030
Mar 04, 2020
The World Market for Cervical Cancer Drugs, Forecast to 2030 - Insights Into Avastin, Bevacizumb, Blemocin, Blenoxane, and More
Mar 02, 2020
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2019 and Highlights Recent Corporate Updates
Feb 27, 2020
FDA Grants Breakthrough Therapy Designation for Debiopharm's Novel Chemo-Radio Sensitizer Debio 1143 for Front-line Treatment of Head & Neck Cancer
Feb 26, 2020
Actinium Announces Actimab-A Plus 7+3 Combination Trial for Newly Diagnosed Acute Myeloid Leukemia Patients
Feb 24, 2020
Top 10 Cancer Drugs Market Study, 2018-2026 - Keytruda Anticipated to Grow at the Highest Rate
Feb 20, 2020
Small Cell Lung Cancer Market Size is Expected to Increase at a CAGR of 13.2% for the Study Period (2017-2030) in the 7MM | Some Market Key Players - AstraZeneca, PharmaMar, EpicentRx, United Therapeutics, Ipsen, G1 Therapeutics, Otsuka Holdings, Takeda